These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 9402509

  • 21. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 22. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
    Fontseré N, Salinas I, Bonal J, Bayés B, Riba J, Torres F, Rios J, Sanmartí A, Romero R.
    Nephrol Dial Transplant; 2006 Aug; 21(8):2152-8. PubMed ID: 16702203
    [Abstract] [Full Text] [Related]

  • 23. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
    Gonzalez Molina M, Morales JM, Marcen R, Campistol JM, Oppenheimer F, Serón D, Gil-Vernet S, Capdevila L, Andrés A, Lampreave I, Del Castillo D, Cabello M, Burgos D, Valdés F, Anaya F, Escuín F, Arias M, Pallardó L, Bustamante J.
    Transplant Proc; 2007 Sep; 39(7):2167-9. PubMed ID: 17889126
    [Abstract] [Full Text] [Related]

  • 24. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 25. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
    Sandborn WJ, Hay JE, Porayko MK, Gores GJ, Steers JL, Krom RA, Wiesner RH.
    Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
    [Abstract] [Full Text] [Related]

  • 26. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Jul 27; 76(2):364-70. PubMed ID: 12883194
    [Abstract] [Full Text] [Related]

  • 27. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K, Kamińska D, Nahaczewska W, Boratyńska M, Owczarek H, Klinger M, Woźniak M, Patrzałek D, Szyber P.
    Transplant Proc; 2006 Jul 27; 38(1):119-22. PubMed ID: 16504680
    [Abstract] [Full Text] [Related]

  • 28. Preservation of renal function after heart transplantation: initial single-center experience with sirolimus.
    De Meester JM, Van Vlem B, Walravens M, Vanderheyden M, Verstreken S, Goethals M, Kerre N, Wellens F.
    Transplant Proc; 2005 May 27; 37(4):1835-8. PubMed ID: 15919481
    [Abstract] [Full Text] [Related]

  • 29. C2 monitoring of cyclosporine in stable renal transplant patients results in lower costs and improved renal function.
    Domínguez J, Fuenzalida D, Norambuena R, Pais E, Cortes Monroy G, Llanos R.
    Transplant Proc; 2005 Apr 27; 37(3):1583-5. PubMed ID: 15866680
    [Abstract] [Full Text] [Related]

  • 30. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
    Schweiger M, Wasler A, Prenner G, Stiegler P, Stadlbauer V, Schwarz M, Tscheliessnigg K.
    Transpl Immunol; 2006 Jun 27; 16(1):46-51. PubMed ID: 16701176
    [Abstract] [Full Text] [Related]

  • 31. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM, Van Buren CT, Radovancevic B, Frazier OH, Janney RP, Powers PL, Golden DL, Giannakis JG, Macris MP, Kerman RH.
    J Heart Lung Transplant; 1991 Jun 27; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [Abstract] [Full Text] [Related]

  • 32. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients.
    Hricik DE, Seliga RM, Fleming-Brooks S, Bartucci MR, Schulak JA.
    Clin Transplant; 1995 Oct 27; 9(5):419-23. PubMed ID: 8541637
    [Abstract] [Full Text] [Related]

  • 33. Contrast-induced nephrotoxicity in renal allograft recipients.
    Ahuja TS, Niaz N, Agraharkar M.
    Clin Nephrol; 2000 Jul 27; 54(1):11-4. PubMed ID: 10939751
    [Abstract] [Full Text] [Related]

  • 34. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
    Carstens J.
    Scand J Urol Nephrol; 2008 Jul 27; 42(3):286-92. PubMed ID: 18432535
    [Abstract] [Full Text] [Related]

  • 35. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation.
    Arora-Gupta N, Davies P, McKiernan P, Kelly DA.
    Pediatr Transplant; 2004 Apr 27; 8(2):145-50. PubMed ID: 15049794
    [Abstract] [Full Text] [Related]

  • 36. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec 27; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 37. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus.
    Bäckman L, Reisaeter AV, Wramner L, Ericzon BG, Salmela K, Brattström C.
    Clin Transplant; 2006 Dec 27; 20(3):336-9. PubMed ID: 16824151
    [Abstract] [Full Text] [Related]

  • 38. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.
    Miozzari M, Ambühl PM.
    Nephrol Dial Transplant; 2004 Oct 27; 19(10):2615-21. PubMed ID: 15280521
    [Abstract] [Full Text] [Related]

  • 39. Kidney function in heart-lung transplant recipients: the effect of low-dosage cyclosporine therapy.
    Imoto EM, Glanville AR, Baldwin JC, Theodore J.
    J Heart Transplant; 1987 Oct 27; 6(4):204-13. PubMed ID: 3117987
    [Abstract] [Full Text] [Related]

  • 40. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC, Srun SW, Wood EG, Belsha CW, Marshall DL, Ferdman BR.
    J Heart Lung Transplant; 2006 May 27; 25(5):518-22. PubMed ID: 16678029
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.